T 1577/11 (Estrogen synthesis inhibitor anastrozole in early breast cancer/ASTRAZENECA) of 03.06.2015
- European Case Law Identifier
- ECLI:EP:BA:2015:T157711.20150603
- Date of decision
- 3 June 2015
- Case number
- T 1577/11
- Petition for review of
- -
- Application number
- 02783305.2
- IPC class
- A61K 31/4196A61P 35/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- USE OF ANASTROZOLE FOR THE TREATMENT OF POST-MENOPAUSAL WOMEN HAVING EARLY BREAST CANCER
- Applicant name
- AstraZeneca AB
- Opponent name
- Hexal AG
Alfred E. Tiefenbacher GmbH & Co. KG
STADA Arzneimittel AG
Helm AG
Teva Pharmaceutical Industries Ltd. - Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56Rules of procedure of the Boards of Appeal Art 13
- Keywords
- Inventive step - reasonable expectation of success (yes)
Late-filed auxiliary request - admitted (no) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.